SCHEMBL19670411

SCHEMBL19670411

C[C@@H]1CCN(C)c2ccc(-c3cccc(C(F)(F)F)c3)nc2N1C(=O)Nc1ccc2c(c1)OCCCO2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.41
▸ LMNA P02545 5/20 0.41
▸ SMN1; SMN2 Q16637 4/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ BRAF P15056 2/20 0.40
▸ POLB P06746 2/20 0.39
▸ TP53 P04637 1/20 0.39
▸ GPR142 Q7Z601 1/20 0.38
▸ CNR1 P21554 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ HPGD P15428 1/20 0.38
▸ IDH1 O75874 1/20 0.38
▸ SCN9A Q15858 1/20 0.37
▸ CA2 P00918 1/20 0.37
▸ CA9 Q16790 1/20 0.37
▸ RAF1 P04049 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ NPC1 O15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19365904 0.86 MAPT (0.43) MAPTLMNASMN1; SMN2HTTALDH1A1
SCHEMBL16775900 0.85 LMNA (0.40) MAPTLMNASMN1; SMN2MAPK1HTT
SCHEMBL17618420 0.84 MAPT (0.44) MAPTLMNASMN1; SMN2MAPK1HTT
SCHEMBL19365708 0.84 MAPT (0.41) MAPTSMN1; SMN2ALDH1A1CA2CA9
SCHEMBL19365254 0.82 HTR2C (0.47) MAPTSMN1; SMN2TP53TSHRNPC1
SCHEMBL19365360 0.82 CA2 (0.38) MAPTLMNASMN1; SMN2HTTBRAF
SCHEMBL19365568 0.82 RHOA (0.50) MAPTLMNAMAPK1HTTALDH1A1
SCHEMBL19365595 0.82 MAPT (0.38) MAPTLMNASMN1; SMN2MAPK1HTT
SCHEMBL19670464 0.81 MAPT (0.40) MAPTLMNASMN1; SMN2HTTALDH1A1
SCHEMBL20632111 0.81 MAPT (0.46) MAPTLMNASMN1; SMN2HTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9834558-B2 Substituted bridged urea analogs as sirtuin modulators GLAXOSMITHKLINE LLC (US) 2017-12-05 — — US disclosed
Send feedback